Large blast in Beirut port area rocks Lebanon's capital, many people hurt    U.S. stocks rose on Monday    Health facilities booked for 5,000 coronavirus violations    Health Ministry: 1,635 New Recoveries Reported, Critical Cases Decreased to 1,983, in Saudi Arabia    Coronavirus may Shrink Global Imbalances further, in 2020, IMF Forecasts    Scores of Saudi businesswomen make the most Unaizah annual date festival    KSrelief distributes shelter materials in Saada governorate    Saudi Arabia records 1,342 new coronavirus cases, 35 deaths    Cop assaulted in Melbourne as hundreds caught violating coronavirus regulations    Amman Stock Market Falls    HRH Crown Prince Congratulates President of Burkina Faso on Independence Day    Saudi Press: Saudi Arabia's Mining Sector Grows 3.1% during 1Q of 2020, Targets SR240 b by 2030    50% of expats working for subcontracting companies in Kuwait to be laid off    Saudi Customs eases restrictions for trucks from GCC states    Farasan Islands set to find a place on UNESCO's MAB List    Spain's former king 'leaves country' amid corruption allegations    UAE foiled 120,038 cyberattacks in July: Report    KSrelief distributes Eid gifts to orphan children in Yemen    China manufacturing PMI at record, equities mixed    UAQ FTZ and UBC forms strategic business alliance    Umm Kulthum hologram to perform at Dubai Opera    UAE Team Emirates on the podium at Strade Bianche    Long-awaited Riyadh derby, SPL games will finally kick-off with safety measures in place    India's top minister Amit Shah tests positive for coronavirus    Aubameyang double helps Arsenal beat Chelsea for 14th FA Cup trophy    Azra Aly, South African pilgrim: ‘The beginning of the rest of my life'    Paris Saint-Germain beats Lyon to win League Cup final    Eid Al-Adha Prayer Performed at the Grand Holy Mosque    Saudi Arabia's PIF ends takeover bid for Newcastle United    Saudi Pro League is back What's left to play for in the remaining eight rounds    Islam calls for protecting communities against epidemics: Sheikh Al-Manea    Pilgrims Perform Dhuhr and Asr Prayers in Arafat Holy Site    Top food magazine pays glowing tribute to ‘the queen of macarons'    Saudi Waste Management Center Signs MoU to Enhance Environmental Sustainability in Saudi Arabia    Bahrain Bourse Rises    Cruise Ships on Saudi Arabia's Red Sea Coasts Launched    Godus brothers passionate to make genuine Saudi films ‘The Book of Sun' to premiere locally during Eid Al-Adha holidays    First-ever bone marrow transplant successfully conducted in UAE    Juventus claim ninth successive Serie A title with win over Sampdoria    NWC Launches Private Sector Long-Term Investment Opportunities For Sewage Treatment Plants' Development and Operation in Saudi Arabia    Muslims in UAE asked to perform Eid Al-Adha prayers at home    Paplo Larazapal appointed international ambassador for Saudi golf    Complementary, Alternative Medicine Practicing 1st Manual Version Issued    Saudi Ithra center launches dialogue sessions with most famous creators in the world    SFDA Implements National Program to Ensure Safety of 10,000 Food Samples    Saudi Surgeon Managed to Remove Kuwaiti Girl's Brain Tumor, as French Physician Declined, in the last Moments    Senior Scholars Council Issues Decision No. 246 Regarding Attendance of Friday Prayer and Prayers at Mosques in a Case of Spread of Epidemic or Fear of its Spread    Custodian of the Two Holy Mosques Addresses Citizens and Muslims on Eid Al-Fitr    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.





RDIF, ChemRar announce increased production of Avifavir for COVID treatment
Published in The Saudi Gazette on 02 - 07 - 2020

The Russian Direct Investment Fund (RDIF), Russia's sovereign wealth fund, and ChemRar Group produced the first 100,000 courses of the Russian coronavirus drug Avifavir in June, significantly exceeding initially planned production levels of 60,000 courses.
In June, the drug was delivered across Russia's 35 regions and to the Republic of Belarus. Agreement has also been reached for deliveries of Avifavir to the Republic of Kazakhstan in the near future. In total, more than 100,000 courses will be produced in July.
The joint venture established by RDIF and ChemRar Group provided an additional opportunity to increase production capacity threefold, up to 300,000 courses per month, which will satisfy domestic demand for Avifavir in the Russian Federation and enable the start of supplies to the international market.
On May 29, 2020, Avifavir received a registration certificate from Russia's Ministry of Health and became the first Favipiravir-based drug in the world approved for the treatment of COVID-19.
On June 3, 2020, the Ministry of Health included Avifavir in the latest seventh edition of the guidelines for the prevention, diagnosis and treatment of new coronavirus infection COVID-19. Avifavir has proven effective in clinical trials, disrupting the reproduction mechanisms of coronavirus.
RDIF and ChemRar have seen significant demand for the drug from abroad. In particular, negotiations are under way on the supply of Avifavir to a number of Latin American countries. In addition, CIS countries, the Middle East and other global regions have expressed interest in acquiring Avifavir.
Kirill Dmitriev, CEO of the Russian Direct Investment Fund, said: "Avifavir is one of the world's most effective coronavirus drugs and produces better results than its peers, including the US drug Remdesivir made by Gilead Sciences.
"Given the US authorities' decision to purchase almost 100% of the manufactured Remdesivir in the coming months and the shortage of effective drugs on the global market, Russia is ready to help other countries in the fight against coronavirus and begin exports of Avifavir.
"The Russian drug is several times cheaper and its tablet form makes it easy to take allowing therapy at the early stages of coronavirus infection.
"More than 50 countries have already expressed an interest in the drug. RDIF and ChemRar intend to expand Avifavir's production and widen its supply geographically over the coming months."
Russian Direct Investment Fund (RDIF) is Russia's sovereign wealth fund established in 2011 to make equity co-investments, primarily in Russia, alongside reputable international financial and strategic investors. RDIF acts as a catalyst for direct investment in the Russian economy. RDIF's management company is based in Moscow.
Currently, RDIF has experience of the successful joint implementation of more than 80 projects with foreign partners totaling more than RUB1.9 tn and covering 95% of the regions of the Russian Federation.
RDIF portfolio companies employ more than 800,000 people and generate revenues which equate to more than 6% of Russia's GDP. RDIF has established joint strategic partnerships with leading international co-investors from more than 18 countries that total more than $40 bn.
ChemRar Group unites R&D service and investment companies in the field of innovative pharmaceuticals for the development and commercialization of innovative medicines, diagnostics, preventive care and new treatments of life-threatening diseases in Russia and abroad. — PRNewswire


Clic here to read the story from its source.